Jo-Anne H Young

JANSSEN GLOBAL SERVICES, LLC

1/11/19 → 2/27/19

Project: Research project

Targeted Clinical Research to Address Select Viral Infections

Fred Hutchinson Cancer Research Center

11/8/17 → 11/7/19

Project: Research project

Virus Diseases

Research

A Randomized, Open-Label, Multicenter Study of Liposomal

INSMED INC

8/1/16 → 11/1/16

Project: Research project

Mycobacterium avium Complex

Amikacin

Inhalation

Multicenter Studies

Lung

A Phase 2b, Randomized, Double-blind, Single-dose

MedImmune, LLC

7/1/16 → 12/31/17

Project: Research project

Human Influenza

Safety

A Phase 2b, Randomized, Controlled Trial Evaluating GS-5

Gilead Sciences, Inc.

7/14/15 → 12/31/17

Project: Research project

Respiratory Syncytial Virus Infections

Randomized Controlled Trials

Lung

Transplant Recipients

GS-5806

A Multicenter Non-Interventional Study to Obtain Retrosp

1/20/15 → 12/31/17

Project: Research project

Adenoviridae Infections

Historically Controlled Study

cidofovir hexadecyloxypropyl ester

A Phase II, Randomized, Double-Blind, Active-Controlled

Summit plc

6/17/14 → 12/31/15

Project: Research project

Safety

Clinical Studies

SMT19969

A Phase III Randomized, Placebo-Controlled Clinical Tria

MERCK AND CO INC

6/11/14 → 12/31/17

Project: Research project

Cytomegalovirus Infections

Randomized Controlled Trials

Placebos

Safety

AIC246

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled

Gilead Sciences, Inc.

6/10/14 → 12/31/17

Project: Research project

Antiviral Agents

Pharmacokinetics

Placebos

Transplants

Safety

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled

Gilead Sciences, Inc.

6/10/14 → 4/30/18

Project: Research project

Antiviral Agents

Pharmacokinetics

Placebos

Transplants

Safety

A Phase 3, Open-Label, Multicenter Study of the Safety

3/15/14 → 4/30/18

Project: Research project

Adenoviridae

Multicenter Studies

Safety

cidofovir hexadecyloxypropyl ester

HZ vaccine in adults with haematologic malignancies- Zos

Cubist Pharmaceuticals, Inc.

GlaxoSmithKline

1/1/14 → 3/31/18

Project: Research project

Herpes Zoster

Hematologic Neoplasms

Vaccines

A Randomized, Double-Blinded, Active-Controlled Study of

Green, J. S. & Young, J. H.

7/1/12 → 6/30/14

Project: Research project

Clostridium difficile

Diarrhea

CB-183,315

A Randomized, Placebo-Controlled, Multi-Site Phase 2 Stu

10/31/11 → 12/31/13

Project: Research project

Hematopoietic Stem Cell Transplantation

Adenoviridae

Placebos

Safety

cidofovir hexadecyloxypropyl ester

A Phase III, Double-Blind, Randomized Study to Evaluate

7/20/11 → 12/31/14

Project: Research project

caspofungin

Candidemia

Candida

Double-Blind Method

Safety

A Phase III, Double Blind, Randomized Study to Evaluate

6/13/11 → 12/31/14

Project: Research project

Mycoses

Double-Blind Method

Fungi

Safety

Voriconazole

Open Label Study of Isavuconazole in the Treatment

6/1/11 → 12/31/14

Project: Research project

Aspergillosis

Mycoses

Fungi

Yeasts

Kidney

Pharmacokinetics, Safety, and Tolerability of Intravenou

SCHERING-PLOUGH CORPORATION

4/1/11 → 6/3/13

Project: Research project

Suspensions

Pharmacokinetics

Safety

posaconazole

Invasive Fungal Infections

A Multicenter, Open-Label Study of CMX001 Treatment of S

11/30/10 → 12/31/12

Project: Research project

Viruses

cidofovir hexadecyloxypropyl ester

A Randomized Double-blind, Placebo-controlled Trial to E

AiCuris GmbH & Co. KG

5/5/10 → 12/20/12

Project: Research project

Antiviral Agents

Placebos

Safety

Pharmaceutical Preparations

Therapeutics

EFFICACY AND SAFETY OF ERAXIS/ECALTA (ANIDULAFUNGIN) COM

PFIZER, INC.

3/15/10 → 6/21/12

Project: Research project

caspofungin

anidulafungin

Candida

Safety

Infection

A Randomized, Multicenter, Single Blinded, ParallelStudy

HOFFMANN-LA ROCHE PHARMACEUTICALS

12/28/09 → 12/31/12

Project: Research project

Safety

Therapeutics

A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROL

11/17/09 → 9/29/12

Project: Research project

Infection Control

Hematopoietic Stem Cells

Placebos

Transplants

Safety

A Phase I randomized, double-blind, placebo-controlled,

GlaxoSmithKline

2/6/09 → 8/21/12

Project: Research project

Herpes Zoster Vaccine

Multicenter Studies

Placebos

Safety

A Prospective, Non-Intervention, Observational Assessmen

MERCK AND CO INC

12/11/08 → 6/30/12

Project: Research project

Aspergillosis

Biomarkers

A Randomized Open Label Study Comparing the Efficacy, Sa

Adamas Pharmaceuticals, Inc.

10/21/08 → 4/26/10

Project: Research project

Oseltamivir

Amantadine

Ribavirin

Safety

thiazole-4-carboxamide adenine dinucleotide

A Phase 4 Study of the Pharmacokinetics of Oral Posacona

SCHERING-PLOUGH CORPORATION

8/2/07 → 12/31/09

Project: Research project

Pharmacokinetics

posaconazole

A Phase 1, open-label Study of the Safety and Parmacokin

7/23/07 → 12/31/09

Project: Research project

Labels

micafungin

A Phase 1, open-label Study of the Safety and Parmacokin

7/23/07 → 12/31/12

Project: Research project

Labels

micafungin

Compare the safety and efficacy of 200 mg PAR-101 Taken

Optimer Pharmaceuticals, Inc.

1/23/07 → 12/31/08

Project: Research project

Clostridium difficile

Vancomycin

Diarrhea

Safety

lipiarmycin

A Randomized, Double-Blind, Placebo-Controlled Study to

ViroPharma Incorporated

10/1/06 → 10/31/09

Project: Research project

Cytomegalovirus

Placebos

Safety

maribavir

A Multicenter, Randomised, Double-Blind, Comparative Stu

MERCK

1/1/06 → 1/1/08

Project: Research project

caspofungin

Double-Blind Method

Safety

Invasive Fungal Infections (IFI) Surveillance Initiative